The safe delivery of vaccines for mass immunisation against COVID-19 is a massive challenge and India will need to significantly ramp up its cold chain facilities,...
The Department of Science and Technology (DST) has shortlisted 51 companies for developing various COVID-19 solutions and 10 of them have been supported for manufacturing and...
As India geared up to fight the COVID-19 crisis, huge efforts were put into increase medical device manufacturing capacity by AiMeD through its members and beyond...
“Atmanirbhar is the catalyst to take India forward and we need to create a roadmap through greater interaction of the government, industry and academia. India has...
Industry experts say while traditionally blood pressure monitors and diabetes kits have formed the bulk of the demand, the pandemic has caused a spike in demand...
More accurate than a rapid antigen test and almost as quick, India’s CRISPR ‘Feluda’ coronavirus test that changes colour on detection of the SARS-CoV-2 virus could be...
The National Pharmaceutical Pricing Authority (NPPA), which regulates drug prices in the country, has capped the prices of medical oxygen and oxygen cylinders over complaints of...
Despite a strong response at the outset of the pandemic, as of Sept 22, India has the world’s fastest growing outbreak of COVID-19 in absolute numbers...
Max Healthcare tweeted a rate card in June indicating the minimum cost of various COVID-19 treatments at one of its Delhi hospitals. The cost for ICU...
India’s government is using the coronavirus pandemic to push its plan to digitise the health records and data of its 1.3 billion people, despite concerns about...
To announce a national mission to digitise health records in the middle of a pandemic—when healthcare infrastructure, financial and human resources are all stretched thin—is either...
The health minister said that flattening the curve will require international multi-sectoral collaborative efforts to ensure that health systems across the world are able to maintain...
In a major relief to patients, the National Pharmaceutical Pricing Authority (NPPA) extended the ceiling prices of orthopedic knee implants for another year. “The ceiling price...
70 per cent of clinical decisions are based on a diagnostic report and yet, in India, all it takes to open and run a medical laboratory...
Rapid antigen tests (RATs) for Covid-19 are cheaper and deliver quicker results but should be no more than an adjunct to the more reliable RT-PCR tests...
Copyright © 2024 Medical Buyer